12/22
08:02 am
ovid
Ovid Therapeutics (NASDAQ:OVID) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
High
Report
Ovid Therapeutics (NASDAQ:OVID) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $2.00 price target on the stock.
12/12
05:52 am
ovid
Ovid Therapeutics (NASDAQ:OVID) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Low
Report
Ovid Therapeutics (NASDAQ:OVID) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
12/12
05:52 am
ovid
Ovid Therapeutics (NASDAQ:OVID) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
Low
Report
Ovid Therapeutics (NASDAQ:OVID) was upgraded by analysts at Roth Capital to a "strong-buy" rating.
12/11
07:55 am
ovid
Rating for OVID
Medium
Report
Rating for OVID
12/11
07:55 am
ovid
Rating for OVID
Medium
Report
Rating for OVID
12/11
06:03 am
ovid
Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
Low
Report
Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
12/11
06:03 am
ovid
Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
Low
Report
Ovid Therapeutics (NASDAQ:OVID) is now covered by analysts at Roth Capital. They set a "buy" rating on the stock.
12/11
05:14 am
ovid
Ovid Therapeutics initiated with a Buy at Roth Capital
Medium
Report
Ovid Therapeutics initiated with a Buy at Roth Capital
12/11
05:14 am
ovid
Ovid Therapeutics initiated with a Buy at Roth Capital
Medium
Report
Ovid Therapeutics initiated with a Buy at Roth Capital